Hypothermia and etomidate. Electroencephalographic aspects

Area of Science:

• Anesthesiology
• Neurophysiology
• Cardiovascular Surgery

Background:

• Coronary artery bypass grafting often involves cardiopulmonary bypass and hypothermia.
• Maintaining adequate cerebral oxygenation during cardiac surgery is critical.
• Etomidate is an anesthetic agent with potential neuroprotective properties.

Purpose of the Study:

• To evaluate the electroencephalogram (EEG) effects of etomidate in patients undergoing coronary surgery.
• To assess the potential neuroprotective role of etomidate during cardiopulmonary bypass and hypothermia.

Main Methods:

• Investigated EEG changes in 15 patients undergoing coronary surgery with extracorporeal circulation (ECC) and moderate hypothermia (29°C).
• Utilized traditional EEG monitoring (bipolar fronto-parietal derivation) in 3 patients.
• Employed Berg-Fourier spectral analysis for EEG assessment in 12 patients.

Main Results:

• Etomidate (0.3 mg/kg) induced EEG depression, manifesting as burst suppression periods of 3-10 seconds, lasting approximately 4 minutes.
• Cerebral electrical activity (0.5-32 Hz) decreased by over 20% for an average of 4.5 minutes post-injection in 7 patients.
• Significant reduction in EEG activity was observed at 29°C during moderate hypothermia.

Conclusions:

• Etomidate causes notable EEG depression in patients undergoing coronary surgery under moderate hypothermia.
• The observed EEG changes warrant further investigation into etomidate's potential neuroprotective effects against cerebral anoxia during cardiac procedures.
• Clinical significance of etomidate-induced EEG depression and its implications for patient outcomes require further study.